Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition

被引:27
作者
Azimzadeh, A
Zorn, GL
Blair, KSA
Zhang, JP
Pfeiffer, S
Harrison, RA
Cozzi, E
White, DJG
Pierson, RN
机构
[1] Vanderbilt Univ, Med Ctr, Dept Cardiothorac Surg, Nashville, TN USA
[2] Nashville VA Med Ctr, Nashville, TN USA
[3] Novartis Pharma AG Co, Imutran Ltd, Cambridge, England
关键词
complement-inhibitors; complement; histamine; human; hyperacute rejection; lung; pig; thromboxane; xenotransplantation;
D O I
10.1034/j.1399-3089.2003.01102.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. The role of complement in hyperacute lung xenograft rejection has not been elucidated. The present study evaluates the effect of complement (C) C3/C5 convertase inhibition on hyperacute rejection of pig lung by human blood. Methods . In an established ex-vivo model, lungs from pigs heterozygous for human decay accelerating factor (hDAF), non-transgenic littermate control pigs, or farm-bred pigs were perfused with fresh human blood that was either unmodified or treated with soluble complement receptor type 1 (sCR1: TP10, 100 mug/ml). Results. Non-transgenic lungs from littermate controls had a median survival time of 35 min (range 5 to 210; P = 0.25 vs. farm-bred piglets: median 5 min, range 5 to 10). Lungs expressing hDAF survived for a median of 90 min (range 10 to 161; P = 0.5 and 0.01 vs. littermate and farm-bred controls, respectively), with sCR1, whereas hDAF (-) lungs failed by 35 min (range 6 to 307), hDAF (+) lungs survived for 330 min (range 39 to 577) [P = 0.002 vs. farm-bred; P = 0.08 vs. hDAF (-); P = 0.17 vs. sCR1/hDAF (-)]. The rise in pulmonary vascular resistance (PVR) at 5 min was blunted only by hDAF (+) with sCR1 (0.26 +/- 0.2 vs. 0.5 to 0.7 mmHg/ml/min for other groups). Plasma C3a and sC5b-9 and tissue deposition of C5b-9 were dramatically diminished using sCR1, and further decreased in association with hDAF. Histamine and thromboxane were produced rapidly in all groups. Conclusion. Complement plays an important role in lung HAR. However, even potent inhibition of C3/C5 convertase, both membrane bound in lung and by a soluble-phase inhibitor in the blood, does not prevent activation of inflammatory responses known to be particularly injurious to the lung. Our findings implicate a role for innate immune pathways resistant to efficient complement regulation. The role of anti-species antibody, coagulation pathway dysregulation, and additional environmental or genetic influences remain to be defined.
引用
收藏
页码:120 / 131
页数:12
相关论文
共 51 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] ATKINSON J P, 1991, Clinical and Experimental Immunology, V86, P27
  • [3] AUCHINCLOSS H, 1990, TRANSPLANT REV, V4, P14
  • [4] Antibodies to human adhesion molecules and von Willebrand factor:: In vitro cross-species reactivity in the xenotransplantation setting
    Azimzadeh, A
    Romain, N
    Vermot-Desroches, C
    Ravanat, C
    Chenard, MP
    Wijdenes, J
    Hervé, P
    Jaeck, D
    Wolf, P
    [J]. XENOTRANSPLANTATION, 1998, 5 (04) : 284 - 291
  • [5] Bennet W, 2000, TRANSPLANTATION, V69, P711
  • [6] Three-month survival of HDAFF transgenic pig hearts transplanted into primates
    Bhatti, FNK
    Schmoeckel, M
    Zaidi, A
    Cozzi, E
    Chavez, G
    Goddard, M
    Dunning, JJ
    Wallwork, J
    White, DJG
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 958 - 958
  • [7] Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model
    Blum, MG
    Collins, BJ
    Chang, AC
    Zhang, JP
    Knaus, SA
    Pierson, RN
    [J]. XENOTRANSPLANTATION, 1998, 5 (01) : 35 - 43
  • [8] Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates
    Charreau, B
    Ménoret, S
    Tesson, L
    Azimzadeh, A
    Audet, M
    Wolf, P
    Marquet, R
    Verbakel, C
    Ijzermans, J
    Cowan, P
    Pearse, M
    d'Apice, A
    Soulillou, JP
    Anegon, I
    [J]. MOLECULAR MEDICINE, 1999, 5 (09) : 617 - 630
  • [9] Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection
    Collins, BJ
    Blum, MG
    Parker, RE
    Chang, AC
    Blair, KSA
    Zorn, GL III
    Christman, BW
    Pierson, RN III
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2001, 90 (06) : 2257 - 2268
  • [10] High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection
    Cowan, PJ
    Somerville, CA
    Shinkel, TA
    Katerelos, M
    Aminian, A
    Romanella, M
    Tange, MJ
    Pearse, MJ
    D'Apice, AJF
    [J]. TRANSPLANTATION, 1998, 65 (06) : 826 - 831